Skip to main content
29/03/2007 - 10:39

C3 to sell CellSpray, close US offices after review

29/03/2007 - 10:39

Bookmark

Save articles for future reference.

Perth-based burns treatment developer Clinical Cell Culture Ltd, or C3, announced it will close its American offices and sell its CellSpray technology after completing a strategic review of its options.

X

To read our articles you will need to either login or subscribe.